Pan-immune-inflammation value and prognostic nutritional index can predict the 2-year recurrence of triple-negative breast cancer patients after radical resection

Key Points

• Two-year recurrence rates can be effectively predicted using pan-immune-inflammation value and prognostic nutritional index in patients with triple-negative breast cancer after radical surgery.
• The analysis showed that using these indicators could significantly aid clinicians in managing patient care and follow-up strategies.
• Both PIV and PNI demonstrate a potential role as biomarkers for recurrence risk, combining immune inflammation and nutritional status for better outcomes.
• These findings highlight the need for incorporating PIV and PNI into routine assessments for tailored treatment plans to improve patient prognosis.